Literature DB >> 32104160

Physical, Laboratory, Radiographic, and Endoscopic Workup for Clostridium difficile Colitis.

Samantha J Baker1, Daniel I Chu2.   

Abstract

Clostridium (reclassified as " Clostridioides ") difficile colitis is a common nosocomial infection associated with increased morbidity and mortality. Like many clinical encounters, a focused history and physical examination will help to guide initial management. Further laboratory testing will assist with diagnosis through stool studies, and blood tests, such as white blood cell counts and serum creatinine, can help to stratify patients into illness severity groups for treatment decisions. Radiographic evaluation can be helpful in patients with severe disease and concern for complicated colitis. Endoscopic evaluation should be carefully considered in patients with suspected mucosal injury secondary to infections and plays a role when an alternative diagnosis is suspected. Treatment options depend on the clinical presentation and can range from antibiotic therapy to emergent surgery to fecal transplantation for recurrent episodes. Care for these patients is often challenging, but through a systemic workup the appropriate treatment may be delivered. © Thieme Medical Publishers.

Entities:  

Keywords:  C. difficile; Clostridium difficile; endoscopy; pseudomembranous colitis

Year:  2020        PMID: 32104160      PMCID: PMC7042018          DOI: 10.1055/s-0039-3400474

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  37 in total

1.  Diagnosis of Clostridium difficile--associated disease: patient selection and test perfection.

Authors:  D N Gerding
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

2.  Clostridium difficile colonization and infection in patients with hepatic cirrhosis.

Authors:  Dong Yan; Yunbo Chen; Tao Lv; Yandi Huang; Jiezuan Yang; Yongtao Li; Jianrong Huang; Lanjuan Li
Journal:  J Med Microbiol       Date:  2017-09-25       Impact factor: 2.472

Review 3.  The pitfalls of laboratory diagnostics of Clostridium difficile infection.

Authors:  M Krutova; M H Wilcox; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2018-03-02       Impact factor: 8.067

Review 4.  Comparative effectiveness of Clostridium difficile treatments: a systematic review.

Authors:  Dimitri M Drekonja; Mary Butler; Roderick MacDonald; Donna Bliss; Gregory A Filice; Thomas S Rector; Timothy J Wilt
Journal:  Ann Intern Med       Date:  2011-12-20       Impact factor: 25.391

5.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

Review 6.  Clostridium difficile-associated diarrhea and colitis.

Authors:  D N Gerding; S Johnson; L R Peterson; M E Mulligan; J Silva
Journal:  Infect Control Hosp Epidemiol       Date:  1995-08       Impact factor: 3.254

7.  Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea.

Authors:  D A Katz; M E Lynch; B Littenberg
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

8.  Utility of perirectal swab specimens for diagnosis of Clostridium difficile infection.

Authors:  Sirisha Kundrapu; Venkata C K Sunkesula; Lucy A Jury; Ajay K Sethi; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

9.  Severe Clostridium difficile colitis.

Authors:  M S Rubin; L E Bodenstein; K C Kent
Journal:  Dis Colon Rectum       Date:  1995-04       Impact factor: 4.585

10.  Does empirical Clostridium difficile infection (CDI) therapy result in false-negative CDI diagnostic test results?

Authors:  Venkata C K Sunkesula; Sirisha Kundrapu; Christine Muganda; Ajay K Sethi; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2013-05-03       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.